Preliminary reports reveal conolidine might inhibit specific ion channels, reducing neuronal excitability and limiting discomfort alerts. This mechanism is particularly appropriate in neuropathic agony, where by abnormal signaling causes persistent soreness. Also, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral to sor